Regenerative Biotechnology
Gencell® CTM Native
Native mesenchymal stem cells for systemic regenerative support.
Injectable solution of native mesenchymal stem cells with immunomodulatory, regenerative, and anti-inflammatory capacity, indicated as adjunct therapy in chronic, autoimmune, inflammatory conditions and dermato-aesthetic procedures.
Composition
Native mesenchymal stem cells.
Pharmaceutical form
Injectable solution.
Presentation
Single-dose vial, 4 ml.
Therapeutic properties
Promote tissue repair and regeneration through immunomodulation, secretion of bioactive factors, inhibition of apoptosis, stimulation of cellular proliferation, and directed transdifferentiation toward injured tissues.
- Immune response modulation.
- Reduction of chronic inflammation.
- Secretion of growth factors.
- Stimulation of angiogenesis.
- Inhibition of cellular apoptosis.
- Promotion of cellular proliferation.
- Transdiferenciación tisular dirigida.
- Support for damaged tissue regeneration.
Mechanism of action & Clinical data
They migrate to the site of injury, modulate inflammation, secrete bioactive factors, inhibit apoptosis, and promote cellular proliferation and differentiation for tissue repair.
Indications
Adjunct therapy in chronic degenerative, autoimmune, chronic inflammatory conditions and dermato-aesthetic rejuvenation procedures.
Administration
Intravenous administration via slow infusion diluted in 0.9% saline solution. No bolus.
Contraindications
Hypersensitivity to any component of the formula. Diagnosis of neoplasia.
Storage
Store refrigerated between 2–8 °C. Protect from direct sunlight. Do not freeze.
